R. F. Furchgott, P. D. Cherry, J. V. Zawadzki, and D. Jothianandan, Endothelial cells as mediators of vasodilation of arteries, J Cardiovasc Pharmacol, vol.6, issue.2, pp.336-343, 1984.

J. B. Hibbs, R. R. Taintor, and Z. Vavrin, Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite, Science, vol.235, pp.473-476, 1987.

D. J. Stuehr and M. A. Marletta, Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide, Proc Natl Acad Sci U S A, vol.82, pp.7738-7742, 1985.

R. F. Furchgott and J. V. Zawadzki, The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature, vol.288, pp.373-376, 1980.

W. P. Arnold, C. K. Mittal, S. Katsuki, and F. Murad, Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations, Proc Natl Acad Sci, vol.74, pp.3203-3207, 1977.

L. J. Ignarro, G. M. Buga, K. S. Wood, R. E. Byrns, and G. Chaudhuri, Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide, Proc Natl Acad Sci, vol.84, pp.9265-9269, 1987.

J. Garthwaite and S. L. Charles, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain, Nature, vol.336, pp.385-388, 1988.

M. W. Foster, T. J. Mcmahon, and J. S. Stamler, S-nitrosylation in health and disease, Trends Mol Med, vol.9, pp.160-168, 2003.

S. Moncada, R. M. Palmer, and E. A. Higgs, Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol Rev, vol.43, pp.109-142, 1991.

A. C. Torregrossa, M. Aranke, and N. S. Bryan, Nitric oxide and geriatrics: Implications in diagnostics and treatment of the elderly, J Geriatr Cardiol, vol.8, pp.230-242, 2011.

D. Bredt and S. Snyder, Nitric-Oxide -a Physiological Messenger Molecule, Annu Rev Biochem, vol.63, pp.175-195, 1994.

J. T. Groves and C. Wang, Nitric oxide synthase: models and mechanisms, Curr Opin Chem Biol, vol.4, pp.687-695, 2000.

W. K. Alderton, C. E. Cooper, and R. G. Knowles, Nitric oxide synthases: structure, function and inhibition, Biochem J, vol.357, pp.593-615, 2001.

C. Nathan and Q. Xie, Nitric-Oxide Synthases -Roles, Tolls, and Controls, Cell, vol.78, pp.915-918, 1994.

C. Farah, L. Michel, and J. Balligand, Nitric oxide signalling in cardiovascular health and disease, Nature Reviews Cardiology, vol.15, pp.292-316, 2018.

A. Calver, J. Collier, and P. Vallance, Nitric-Oxide and Cardiovascular Control, Exp Physiol, vol.78, pp.303-326, 1993.

R. M. Palmer, D. S. Ashton, and S. Moncada, Vascular endothelial cells synthesize nitric oxide from L-arginine, Nature, vol.333, pp.664-666, 1988.

J. Dinerman, C. Lowenstein, and S. Snyder, Molecular Mechanisms of Nitric-Oxide Regulation -Potential Relevance to Cardiovascular-Disease, CircRes, vol.73, pp.217-222, 1993.

C. Napoli, F. De-nigris, S. Williams-ignarro, O. Pignalosa, V. Sica et al., Nitric oxide and atherosclerosis: An update, Nitric Oxide-Biol Chem, vol.15, pp.265-279, 2006.

U. Foerstermann, Nitric oxide and oxidative stress in vascular disease, Pflugers Arch, vol.459, pp.923-939, 2010.

A. Chatterjee and J. D. Catravas, Endothelial nitric oxide (NO) and its pathophysiologic regulation, Vasc Pharmacol, vol.49, pp.134-140, 2008.

Y. Higashi, K. Noma, M. Yoshizumi, and Y. Kihara, Endothelial Function and Oxidative Stress in Cardiovascular Diseases, Circ J, vol.73, pp.411-418, 2009.

H. G. Li and U. Forstermann, Nitric oxide in the pathogenesis of vascular disease, J Pathol, vol.190, pp.244-254, 2000.

A. Debelder, R. Macallister, M. Radomski, S. Moncada, and P. Vallance, Effects of S-Nitroso-Glutathione in the Human Forearm Circulation -Evidence for Selective-Inhibition of Platelet Activation, Cardiovasc Res, vol.28, pp.691-694, 1994.

J. O. Lundberg, Nitric Oxide Metabolites and Cardiovascular Disease: Markers, Mediators, or Both?, Journal of the American College of Cardiology, vol.47, pp.580-581, 2006.

B. C. Smith and M. A. Marletta, Mechanisms of S-nitrosothiol formation and selectivity in nitric oxide signaling, Curr Opin Chem Biol, vol.16, pp.498-506, 2012.

Y. Zhang and N. Hogg, S-Nitrosothiols: cellular formation and transport, Free Radical Biology and Medicine, vol.38, pp.831-838, 2005.

N. Hogg, The biochemistry and physiology of S-nitrosothiols, Annu Rev Pharmacol Toxicol, vol.42, pp.585-600, 2002.

J. Loscalzo and G. Welch, Nitric oxide and its role in the cardiovascular system, Prog Cardiovasc Dis, vol.38, pp.87-104, 1995.

G. Richardson and N. Benjamin, Potential therapeutic uses for S-nitrosothiols, Clin Sci, vol.102, pp.99-105, 2002.

P. G. Wang, M. Xian, X. P. Tang, X. J. Wu, Z. Wen et al., Nitric oxide donors: Chemical activities and biological applications, Chem Rev, vol.102, pp.1091-1134, 2002.

A. W. Carpenter and M. H. Schoenfisch, Nitric oxide release: Part II. Therapeutic applications, Chem Soc Rev, vol.41, pp.3742-3752, 2012.

J. R. Parratt, Nitroglycerin--the first one hundred years: new facts about an old drug, J Pharm Pharmacol, vol.31, pp.801-809, 1979.

L. D. Nelin and G. M. Hoffman, The use of inhaled nitric oxide in a wide variety of clinical problems, Pediatr Clin North Am, vol.45, pp.531-548, 1998.

. Nitroprusside, Drugs and Lactation Database (LactMed). National Library of Medicine (US): Bethesda (MD), 2006.

A. Cobb and L. Thornton, Sodium Nitroprusside as a Hyperinflation Drug and Therapeutic Alternatives, J Pharm Pract, vol.31, pp.374-381, 2018.

R. W. Ware and S. B. King, P-Nitrosophosphate compounds: new N-O heterodienophiles and nitroxyl delivery agents, J Org Chem, vol.65, pp.8725-8729, 2000.

A. Ellis, C. G. Li, and M. J. Rand, Differential actions of L-cysteine on responses to nitric oxide, nitroxyl anions and EDRF in the rat aorta, Br J Pharmacol, vol.129, pp.315-322, 2000.

S. S. Ng and C. C. Pang, Venous versus arterial actions of diethylamine/nitric oxide (DEA/NO) complex and S-nitroso-N-acetylpenicillamine (SNAP) in vivo, Br J Pharmacol, vol.125, pp.1247-1251, 1998.

P. Ferná-ndez-tomé, I. Lizasoain, J. C. Leza, P. Lorenzo, and M. A. Moro, Neuroprotective effects of DETA-NONOate, a nitric oxide donor, on hydrogen peroxide-induced neurotoxicity in cortical neurones, Neuropharmacology, vol.38, pp.1307-1315, 1999.

K. Schönafinger, Heterocyclic NO prodrugs, Farmaco, vol.54, pp.316-320, 1999.

L. J. Ignarro, C. Napoli, and J. Loscalzo, Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide -An overview, CircRes, vol.90, pp.21-28, 2002.

C. A. Gruetter, D. Y. Gruetter, J. E. Lyon, P. J. Kadowitz, and L. J. Ignarro, Relationship between cyclic guanosine 3':5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin, J Pharmacol Exp Ther, vol.219, pp.181-186, 1981.

C. A. Gruetter, B. K. Barry, D. B. Mcnamara, D. Y. Gruetter, P. J. Kadowitz et al., Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine, J Cyclic Nucleotide Res, vol.5, pp.211-224, 1979.

J. J. Mcguire, D. J. Anderson, B. J. Mcdonald, R. Narayanasami, and B. M. Bennett, Inhibition of NADPH-cytochrome P450 reductase and glyceryl trinitrate biotransformation by diphenyleneiodonium sulfate, Biochem Pharmacol, vol.56, pp.881-893, 1998.

M. A. Kurz, T. D. Boyer, R. Whalen, T. E. Peterson, and D. G. Harrison, Nitroglycerin metabolism in vascular tissue: role of glutathione S-transferases and relationship between NO. and NO2-formation, Biochem J, vol.292, issue.2, pp.545-550, 1993.

T. Münzel, H. Sayegh, B. A. Freeman, M. M. Tarpey, and D. G. Harrison, Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance, J Clin Invest, vol.95, pp.187-194, 1995.

T. Münzel, S. Kurz, S. Rajagopalan, M. Thoenes, W. R. Berrington et al., Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membranebound NADH oxidase. A new action for an old drug, J Clin Invest, vol.98, pp.1465-1470, 1996.

L. Skatchkov-null and . Null, Urinary NItrotyrosine Content as a Marker of Peroxynitrite-induced Tolerance to Organic NItrates, J Cardiovasc Pharmacol Ther, vol.2, pp.85-96, 1997.

C. R. Molina, J. W. Andresen, R. M. Rapoport, S. Waldman, and F. Murad, Effect of in vivo nitroglycerin therapy on endothelium-dependent and independent vascular relaxation and cyclic GMP accumulation in rat aorta, J Cardiovasc Pharmacol, vol.10, pp.371-378, 1987.

T. Münzel, H. Li, H. Mollnau, U. Hink, E. Matheis et al., Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability, Circ Res, vol.86, pp.7-12, 2000.

K. C. Fylaktakidou, D. J. Hadjipavlou-litina, K. E. Litinas, E. A. Varella, and D. N. Nicolaides, Recent developments in the chemistry and in the biological applications of amidoximes, Curr Pharm Des, vol.14, pp.1001-1047, 2008.

B. Clement, Reduction of N-hydroxylated compounds: amidoximes (Nhydroxyamidines) as pro-drugs of amidines, Drug Metab Rev, vol.34, pp.565-579, 2002.

S. Kang, H. Zeng, H. Li, H. Wang, and W. P. .-4-chlorobenzamidoxime, Acta Crystallographica Section E, vol.63, pp.4698-4698, 2007.

H. Al-sa'doni and A. Ferro, S-Nitrosothiols: a class of nitric oxide-donor drugs, Clin Sci, vol.98, pp.507-520, 2000.

D. L. Williams, S-nitrosothiols and role of metal ions in decomposition to nitric oxide, Meth Enzymol, vol.268, pp.299-308, 1996.

R. J. Singh, N. Hogg, J. Joseph, and B. Kalyanaraman, Mechanism of nitric oxide release from S-nitrosothiols, J Biol Chem, vol.271, pp.18596-18603, 1996.

D. J. Sexton, A. Muruganandam, D. J. Mckenney, and B. Mutus, Visible light photochemical release of nitric oxide from S-nitrosoglutathione: potential photochemotherapeutic applications, Photochem Photobiol, vol.59, pp.463-467, 1994.

K. A. Broniowska, A. R. Diers, N. Hogg, and . S-nitrosoglutathione, Biochim Biophys Acta-Gen Subj, vol.1830, pp.3173-3181, 2013.

N. Hogg, Biological chemistry and clinical potential of S-nitrosothiols, Free Radical Biology and Medicine, vol.28, pp.1478-1486, 2000.

N. Hogg, The kinetics of S-transnitrosation--a reversible second-order reaction, Anal Biochem, vol.272, pp.257-262, 1999.

K. Wang, Z. Wen, W. Zhang, M. Xian, J. P. Cheng et al., Equilibrium and kinetics studies of transnitrosation between S-nitrosothiols and thiols, Bioorg Med Chem Lett, vol.11, pp.433-436, 2001.

A. R. Butler, H. H. Al-sa'doni, I. L. Megson, and F. W. Flitney, Synthesis, decomposition, and vasodilator action of some new S-nitrosated dipeptides, Nitric Oxide, vol.2, pp.193-202, 1998.

J. S. Stamler, S-nitrosothiols and the bioregulatory actions of nitrogen oxides through reactions with thiol groups, Curr Top Microbiol Immunol, vol.196, pp.19-36, 1995.

D. R. Arnelle and J. S. Stamler, NO+, NO, and NO-donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation, Arch Biochem Biophys, vol.318, pp.279-285, 1995.

N. Hogg, R. J. Singh, and B. Kalyanaraman, The role of glutathione in the transport and catabolism of nitric oxide, FEBS Lett, vol.382, pp.223-228, 1996.

S. Mohr, H. Hallak, A. De-boitte, E. G. Lapetina, and B. Brüne, Nitric oxide-induced Sglutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase, J Biol Chem, vol.274, pp.9427-9430, 1999.

Y. Ji, T. P. Akerboom, H. Sies, and J. A. Thomas, S-nitrosylation and S-glutathiolation of protein sulfhydryls by S-nitroso glutathione, Arch Biochem Biophys, vol.362, pp.67-78, 1999.

C. M. Padgett and A. R. Whorton, Cellular responses to nitric oxide: role of protein Sthiolation/dethiolation, Arch Biochem Biophys, vol.358, pp.232-242, 1998.

A. I. Haj-yehia and L. Z. Benet, In vivo depletion of free thiols does not account for nitroglycerin-induced tolerance: a thiol-nitrate interaction hypothesis as an alternative explanation for nitroglycerin activity and tolerance, J Pharmacol Exp Ther, vol.278, pp.1296-1305, 1996.

I. Hornyak, E. Pankotai, L. Kiss, and Z. Lacza, Current Developments in the Therapeutic Potential of S-Nitrosoglutathione, an Endogenous NO-Donor Molecule, Curr Pharm Biotechnol, vol.12, pp.1368-1374, 2011.

T. W. Hart, Some observations concerning the S-nitroso and S-phenylsulphonyl derivatives of L-cysteine and glutathione, Tetrahedron Letters, vol.26, pp.2013-2016, 1985.

M. Parent, F. Dahboul, R. Schneider, I. Clarot, P. Maincent et al., Complete Physicochemical Identity Card of S-nitrosoglutathione, Current Pharmaceutical Analysis, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00807801

D. E. Jensen, G. K. Belka, D. Bois, and G. C. , S-Nitrosoglutathione is a substrate for rat alcohol dehydrogenase class III isoenzyme, Biochem J, vol.331, pp.659-668, 1998.

M. Koivusalo, M. Baumann, and L. Uotila, Evidence for the identity of glutathione-dependent formaldehyde dehydrogenase and class III alcohol dehydrogenase, FEBS Lett, vol.257, pp.105-109, 1989.

C. A. Staab, T. Hartmanová, Y. El-hawari, B. Ebert, M. Kisiela et al., Studies on reduction of S-nitrosoglutathione by human carbonyl reductases 1 and 3, Chem Biol Interact, vol.191, pp.95-103, 2011.

S. D. Barnett and I. Buxton, The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy, Crit Rev Biochem Mol Biol, vol.52, pp.340-354, 2017.

M. Benhar, M. T. Forrester, D. T. Hess, and J. S. Stamler, Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins, Science, vol.320, pp.1050-1054, 2008.

R. Sengupta and A. Holmgren, Thioredoxin and thioredoxin reductase in relation to reversible S-nitrosylation, Antioxid Redox Signal, vol.18, pp.259-269, 2013.

D. A. Mitchell and M. A. Marletta, Thioredoxin catalyzes the S-nitrosation of the caspase-3 active site cysteine, Nat Chem Biol, vol.1, pp.154-158, 2005.

A. Zai, M. A. Rudd, A. W. Scribner, and J. Loscalzo, Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide, J Clin Invest, vol.103, pp.393-399, 1999.

I. Sliskovic, A. Raturi, and B. Mutus, Characterization of the S-denitrosation activity of protein disulfide isomerase, J Biol Chem, vol.280, pp.8733-8741, 2005.

R. D. Allison, gamma-Glutamyl transpeptidase: kinetics and mechanism, Meth Enzymol, vol.113, pp.419-437, 1985.

A. Meister, S. S. Tate, and O. W. Griffith, Gamma-glutamyl transpeptidase, Meth Enzymol, vol.77, pp.237-253, 1981.

W. A. Abbott, O. W. Griffith, and A. Meister, Gamma-glutamyl-glutathione. Natural occurrence and enzymology, J Biol Chem, vol.261, pp.13657-13661, 1986.

Y. Hou, Z. Guo, J. Li, and P. G. Wang, Seleno compounds and glutathione peroxidase catalyzed decomposition of S-nitrosothiols, Biochem Biophys Res Commun, vol.228, pp.88-93, 1996.

M. Trujillo, M. N. Alvarez, G. Peluffo, B. A. Freeman, and R. Radi, Xanthine oxidase-mediated decomposition of S-nitrosothiols, J Biol Chem, vol.273, pp.7828-7834, 1998.

D. Jourd'heuil, F. S. Laroux, A. M. Miles, D. A. Wink, and M. B. Grisham, Effect of superoxide dismutase on the stability of S-nitrosothiols, Arch Biochem Biophys, vol.361, pp.323-330, 1999.

C. A. Staab, M. Hellgren, and J. Höög, Medium-and short-chain dehydrogenase/reductase gene and protein families : Dual functions of alcohol dehydrogenase 3: implications with focus on formaldehyde dehydrogenase and S-nitrosoglutathione reductase activities, Cell Mol Life Sci, vol.65, pp.3950-3960, 2008.

B. Ramsay, M. Radomski, A. Debelder, J. Martin, and P. Lopezjaramillo, Systemic Effects of S-Nitroso-Glutathione in the Human Following Intravenous-Infusion, Br J Clin Pharmacol, vol.40, pp.101-102, 1995.

E. J. Langford, R. J. Wainwright, and J. F. Martin, Platelet activation in acute myocardial infarction and unstable angina is inhibited by nitric oxide donors, Arterioscler Thromb Vasc Biol, vol.16, pp.51-55, 1996.

E. Salas, E. J. Langford, M. T. Marrinan, J. F. Martin, S. Moncada et al., Snitrosoglutathione inhibits platelet activation and deposition in coronary artery saphenous vein grafts in vitro and in vivo, Heart, vol.80, pp.146-150, 1998.

C. Lees, E. Langford, A. S. Brown, A. Debelder, A. Pickles et al., The effects of S-nitrosoglutathione on platelet activation, hypertension, and uterine and fetal Doppler in severe preeclampsia, Obstet Gynecol, vol.88, pp.14-19, 1996.

E. Langford, A. Brown, R. Wainwright, A. Debelder, M. Thomas et al., Inhibition of Platelet Activity by S-Nitrosoglutathione During Coronary Angioplasty, Lancet, vol.344, pp.1458-1460, 1994.

Z. Kaposzta, P. A. Baskerville, M. D. Fraser, S. Martin, J. F. Markus et al., L-arginine and S-nitrosoglutathione reduce embolization in humans, Circulation, vol.103, pp.2371-2375, 2001.

Z. Kaposzta, A. Clifton, J. Molloy, J. F. Martin, and H. S. Markus, S-nitrosoglutathione reduces asymptomatic embolization after carotid angioplasty, Circulation, vol.106, pp.3057-3062, 2002.

J. Molloy, J. F. Martin, P. A. Baskerville, S. Fraser, and H. S. Markus, S-nitrosoglutathione reduces the rate of embolization in humans, Circulation, vol.98, pp.1372-1375, 1998.

S. Moncada, R. M. Palmer, and E. A. Higgs, Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol Rev, vol.43, pp.109-142, 1991.

R. Macallister, A. Calver, J. Riezebos, J. Collier, and P. Vallance, Relative Potency and Arteriovenous Selectivity of Nitrovasodilators on Human Blood-Vessels -an Insight into the Targeting of Nitric-Oxide Delivery, J Pharmacol Exp Ther, vol.273, pp.154-160, 1995.

T. Rassaf, P. Kleinbongard, M. Preik, A. Dejam, P. Gharini et al., Plasma nitrosothiols contribute to the systemic vasodilator effects of intravenously applied NO -Experimental and clinical study on the fate of NO in human blood, CircRes, vol.91, pp.470-477, 2002.

H. Duong, Z. Dong, L. Su, C. Boyer, J. George et al., The use of nanoparticles to deliver nitric oxide to hepatic stellate cells for treating liver fibrosis and portal hypertension, Small, vol.11, pp.2291-2304, 2015.

A. B. Seabra, A. Fitzpatrick, J. Paul, D. Oliveira, M. G. Weller et al., Topically applied Snitrosothiol-containing hydrogels as experimental and pharmacological nitric oxide donors in human skin, Br J Dermatol, vol.151, pp.977-983, 2004.

G. Bannenberg, J. Xue, L. Engman, I. Cotgreave, P. Moldeus et al., Characterization of Bronchodilator Effects and Fate of S-Nitrosothiols, J Pharmacol Exp Ther, vol.272, pp.1238-1245, 1995.

K. P. Hurley, L. L. Bovet, and J. S. Stamler, Stable S-nitrosthiol formulations, patent cooperation treaty, 2005.

A. B. Seabra, G. De-souza, L. L. Da-rocha, M. N. Eberlin, and M. G. De-oliveira, Snitrosoglutathione incorporated in poly(ethylene glycol) matrix: potential use for topical nitric oxide delivery, Nitric Oxide-Biol Chem, vol.11, pp.263-272, 2004.

A. B. Seabra, D. Rocha, L. L. Eberlin, M. N. , D. Oliveira et al., Solid films of blended poly(vinyl alcohol)/poly(vinyl pyrrolidone) for topical S-nitrosoglutathione and nitric oxide release, J Pharm Sci, vol.94, pp.994-1003, 2005.

A. B. Seabra and M. G. De-oliveira, Poly(vinyl alcohol) and poly(vinyl pyrrolidone) blended films for local nitric oxide release, Biomaterials, vol.25, pp.3773-3782, 2004.

. Simões-mm-de, . Sg, and M. G. De-oliveira, Poly(vinyl alcohol) films for topical delivery of Snitrosoglutathione: effect of freezing-thawing on the diffusion properties, J Biomed Mater Res Part B Appl Biomater, vol.93, pp.416-424, 2010.

J. O. Kim, J. Noh, R. K. Thapa, N. Hasan, M. Choi et al., Nitric oxide-releasing chitosan film for enhanced antibacterial and in vivo wound-healing efficacy, Int J Biol Macromol, vol.79, pp.217-225, 2015.

J. Yoo, G. Acharya, and C. H. Lee, In vivo evaluation of vaginal films for mucosal delivery of nitric oxide, Biomaterials, vol.30, pp.3978-3985, 2009.

S. M. Shishido, A. B. Seabra, W. Loh, G. De-oliveira, and M. , Thermal and photochemical nitric oxide release from S-nitrosothiols incorporated in Pluronic F127 gel: potential uses for local and controlled nitric oxide release, Biomaterials, vol.24, pp.3543-3553, 2003.

R. Vercelino, T. M. Cunha, E. S. Ferreira, F. Q. Cunha, S. H. Ferreira et al., Skin vasodilation and analgesic effect of a topical nitric oxide-releasing hydrogel, J Mater Sci Mater Med, vol.24, pp.2157-2169, 2013.

J. L. Georgii, T. P. Amadeu, A. B. Seabra, M. G. De-oliveira, M. et al., Topical Snitrosoglutathione-releasing hydrogel improves healing of rat ischaemic wounds, J Tissue Eng Regen Med, vol.5, pp.612-619, 2011.

M. T. Pelegrino, D. R. De-araújo, and A. B. Seabra, S-nitrosoglutathione-containing chitosan nanoparticles dispersed in Pluronic F-127 hydrogel: Potential uses in topical applications, Journal of Drug Delivery Science and Technology, vol.43, pp.211-220, 2018.

S. P. Hlaing, J. Kim, J. Lee, N. Hasan, J. Cao et al., S-Nitrosoglutathione loaded poly(lactic-co-glycolic acid) microparticles for prolonged nitric oxide release and enhanced healing of methicillin-resistant Staphylococcus aureus-infected wounds, Eur J Pharm Biopharm, vol.132, pp.94-102, 2018.

M. Parent, A. Boudier, I. Fries, A. Gosty?ska, M. Rychter et al., Nitric oxideeluting scaffolds and their interaction with smooth muscle cells in vitro, J Biomed Mater Res A, vol.103, pp.3303-3311, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01277820

M. Parent, A. Boudier, J. Perrin, C. Vigneron, P. Maincent et al., Situ Microparticles Loaded with S-Nitrosoglutathione Protect from Stroke, vol.10, p.144659, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01279697

A. De-mel, N. Naghavi, B. G. Cousins, I. Clatworthy, G. Hamilton et al., Nitric oxide-eluting nanocomposite for cardiovascular implants, J Mater Sci Mater Med, vol.25, pp.917-929, 2014.

G. Acharya, C. H. Lee, and Y. Lee, Optimization of cardiovascular stent against restenosis: factorial design-based statistical analysis of polymer coating conditions, PLoS ONE, vol.7, p.43100, 2012.

M. D. Bhavsar and M. M. Amiji, Polymeric nano-and microparticle technologies for oral gene delivery, Expert Opin Drug Deliv, vol.4, pp.197-213, 2007.

A. Shunmugavel, M. Khan, F. M. Hughes, J. T. Purves, A. Singh et al., S-Nitrosoglutathione protects the spinal bladder: Novel therapeutic approach to post-spinal cord injury bladder remodeling: GSNO Protects Spinal Bladder, Neurourology and Urodynamics, vol.34, pp.519-526, 2015.

S. Giri, R. Rattan, M. Deshpande, J. L. Maguire, Z. Johnson et al., Preclinical Therapeutic Potential of a Nitrosylating Agent in the Treatment of Ovarian Cancer, PLoS ONE, vol.9, p.97897, 2014.

N. Nath, O. Morinaga, and I. Singh, S-nitrosoglutathione a Physiologic Nitric Oxide Carrier Attenuates Experimental Autoimmune Encephalomyelitis, Journal of Neuroimmune Pharmacology, vol.5, pp.240-251, 2010.

E. Haq, B. Rohrer, N. Nath, C. E. Crosson, and I. Singh, S-nitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP161-180)-induced experimental autoimmune uveitis, J Ocular Pharmacol Ther, vol.23, pp.221-231, 2007.

W. Wu, C. Gaucher, R. Diab, I. Fries, Y. Xiao et al., Time lasting Snitrosoglutathione polymeric nanoparticles delay cellular protein S-nitrosation, European Journal of Pharmaceutics and Biopharmaceutics, vol.89, pp.1-8, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01281136

W. Wu, C. Gaucher, I. Fries, X. Hu, P. Maincent et al., Polymer nanocomposite particles of S -nitrosoglutathione: A suitable formulation for protection and sustained oral delivery, International Journal of Pharmaceutics, vol.495, pp.354-361, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01281137

W. Wu, C. Perrin-sarrado, M. H. Lartaud, I. Maincent, P. Hu et al., Polymer nanocomposites enhance S -nitrosoglutathione intestinal absorption and promote the formation of releasable nitric oxide stores in rat aorta, Nanomedicine: Nanotechnology, Biology and Medicine, vol.12, pp.1795-1803, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01493332

L. M. Ensign, R. Cone, and J. Hanes, Oral Drug Delivery with Polymeric Nanoparticles: The Gastrointestinal Mucus Barriers, Adv Drug Deliv Rev, vol.64, pp.557-570, 2012.

A. A. Date, J. Hanes, and L. M. Ensign, Nanoparticles for oral delivery: Design, evaluation and state-of-the-art, Journal of Controlled Release, vol.240, pp.504-526, 2016.

R. F. Pagels, &. Prud, and . Rk, Polymeric nanoparticles and microparticles for the delivery of peptides, biologics, and soluble therapeutics, Journal of Controlled Release, vol.219, pp.519-535, 2015.

Y. Yun, Y. W. Cho, and K. Park, Nanoparticles for oral delivery: Targeted nanoparticles with peptidic ligands for oral protein delivery, Adv Drug Deliv Rev, vol.65, pp.822-832, 2013.

M. George and T. E. Abraham, Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review, J Control Release, vol.114, pp.1-14, 2006.

C. Chang, Y. Lin, C. Yeh, Y. Chen, S. Chiou et al., Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of Helicobacter pylori, Biomacromolecules, vol.11, pp.133-142, 2010.

Y. Lin, J. Lin, S. Chou, S. Chang, C. Chung et al., Berberine-loaded targeted nanoparticles as specific Helicobacter pylori eradication therapy: in vitro and in vivo study, Nanomedicine (Lond), vol.10, pp.57-71, 2015.

H. He, P. Wang, C. Cai, R. Yang, and X. Tang, VB12-coated Gel-Core-SLN containing insulin: Another way to improve oral absorption, Int J Pharm, vol.493, pp.451-459, 2015.

A. Verma, S. Sharma, P. K. Gupta, A. Singh, B. V. Teja et al., Vitamin B12 functionalized layer by layer calcium phosphate nanoparticles: A mucoadhesive and pH responsive carrier for improved oral delivery of insulin, Acta Biomater, vol.31, pp.288-300, 2016.

M. R. Aji-alex, A. J. Chacko, S. Jose, and E. B. Souto, Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting, Eur J Pharm Sci, vol.42, pp.11-18, 2011.

Z. Zhang, F. Gao, H. Bu, J. Xiao, and Y. Li, Solid lipid nanoparticles loading candesartan cilexetil enhance oral bioavailability: in vitro characteristics and absorption mechanism in rats, Nanomedicine, vol.8, pp.740-747, 2012.

D. Gugulothu, A. Kulkarni, V. Patravale, and P. Dandekar, pH-sensitive nanoparticles of curcumin-celecoxib combination: evaluating drug synergy in ulcerative colitis model, J Pharm Sci, vol.103, pp.687-696, 2014.

P. Couvreur, Nanoparticles in drug delivery: Past, present and future, Advanced Drug Delivery Reviews, vol.65, pp.21-23, 2013.

D. S. Kohane, Microparticles and nanoparticles for drug delivery, Biotechnology and Bioengineering, vol.96, pp.203-209, 2007.

P. Couvreur and F. Puisieux, Nanoparticles and Microparticles for the Delivery of Polypeptides and Proteins, Adv Drug Deliv Rev, vol.10, pp.141-162, 1993.

M. Kumar, Nano and microparticles as controlled drug delivery devices, Journal of Pharmacy and Pharmaceutical Sciences, 2000.

R. C. Mundargi, V. R. Babu, V. Rangaswamy, P. Patel, and T. M. Aminabhavi, Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-coglycolide) and its derivatives, J Control Release, vol.125, pp.193-209, 2008.

M. M. Doherty and W. N. Charman, The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?, Clin Pharmacokinet, vol.41, pp.235-253, 2002.

D. R. Friend, Drug delivery to the small intestine, Curr Gastroenterol Rep, vol.6, pp.371-376, 2004.

Y. Gotoh, H. Suzuki, S. Kinoshita, T. Hirohashi, Y. Kato et al., Involvement of an organic anion transporter (canalicular multispecific organic anion transporter/multidrug resistance-associated protein 2) in gastrointestinal secretion of glutathione conjugates in rats, J Pharmacol Exp Ther, vol.292, pp.433-439, 2000.

J. L. Madara, Regulation of the movement of solutes across tight junctions, Annu Rev Physiol, vol.60, pp.143-159, 1998.

M. Tomita, M. Shiga, M. Hayashi, and S. Awazu, Enhancement of colonic drug absorption by the paracellular permeation route, Pharm Res, vol.5, pp.341-346, 1988.

W. Rubas, M. E. Cromwell, Z. Shahrokh, J. Villagran, T. N. Nguyen et al., Flux measurements across Caco-2 monolayers may predict transport in human large intestinal tissue, J Pharm Sci, vol.85, pp.165-169, 1996.

J. R. Pappenheimer, Physiological regulation of transepithelial impedance in the intestinal mucosa of rats and hamsters, J Membr Biol, vol.100, pp.137-148, 1987.

P. H. Barry, Ionic permeation mechanisms in epithelia: biionic potentials, dilution potentials, conductances, and streaming potentials, Meth Enzymol, vol.171, pp.678-715, 1989.

D. W. Powell, Barrier function of epithelia, Am J Physiol, vol.241, pp.275-288, 1981.

M. Shakweh, G. Ponchel, and E. Fattal, Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery, Expert Opin Drug Deliv, vol.1, pp.141-163, 2004.

P. S. Burton, R. A. Conradi, and A. R. Hilgers, B) Mechanisms of peptide and protein absorption: (2) Transcellular mechanism of peptide and protein absorption: passive aspects, Advanced Drug Delivery Reviews, vol.7, pp.365-385, 1991.

A. T. Florence, Issues in oral nanoparticle drug carrier uptake and targeting, J Drug Target, vol.12, pp.65-70, 2004.

P. J. Giannasca, K. T. Giannasca, A. M. Leichtner, and M. R. Neutra, Human intestinal M cells display the sialyl Lewis A antigen, Infect Immun, vol.67, pp.946-953, 1999.

A. Frey and M. R. Neutra, Targeting of mucosal vaccines to Peyer's patch M cells, Behring Inst Mitt, pp.376-389, 1997.

M. A. Clark, B. H. Hirst, and M. A. Jepson, Lectin-mediated mucosal delivery of drugs and microparticles, Adv Drug Deliv Rev, vol.43, pp.207-223, 2000.

A. Buda, C. Sands, and M. A. Jepson, Use of fluorescence imaging to investigate the structure and function of intestinal M cells, Adv Drug Deliv Rev, vol.57, pp.123-134, 2005.

F. Schué, Encyclopedia of controlled drug delivery, Polymer International, vol.1, pp.263-263, 1999.

L. Barthe, J. Woodley, and G. Houin, Gastrointestinal absorption of drugs: methods and studies, Fundam Clin Pharmacol, vol.13, pp.154-168, 1999.

J. P. Bai and G. L. Amidon, Structural specificity of mucosal-cell transport and metabolism of peptide drugs: implication for oral peptide drug delivery, Pharm Res, vol.9, pp.969-978, 1992.

R. Gj, The potential use of receptor-mediated endocytosis for oral drug delivery, Adv Drug Deliv Rev, vol.46, pp.59-73, 2001.

M. Camilleri, A. Nadeau, J. Lamsam, S. L. Nord, M. Ryks et al., Understanding Measurements of Intestinal Permeability in Healthy Humans with Urine Lactulose and Mannitol Excretion, Neurogastroenterol Motil, vol.22, pp.15-26, 2010.

L. Wang, C. Llorente, P. Hartmann, A. Yang, P. Chen et al., Methods to determine intestinal permeability and bacterial translocation during liver disease, J Immunol Methods, vol.421, pp.44-53, 2015.

M. Gonzá-lez-gonzá-lez, D. Az-zepeda, C. Eyzaguirre-velá-squez, J. Gonzá-lez-arancibia, C. Bravo et al., Investigating Gut Permeability in Animal Models of Disease, Front Physiol, vol.9, 2019.

L. L. Clarke, A guide to Ussing chamber studies of mouse intestine, Am J Physiol Gastrointest Liver Physiol, vol.296, pp.1151-1166, 2009.

S. Gordon, M. Daneshian, J. Bouwstra, F. Caloni, S. Constant et al., Non-animal models of epithelial barriers (skin, intestine and lung) in research, industrial applications and regulatory toxicology, ALTEX, vol.32, pp.327-378, 2015.

C. Moon, K. L. Vandussen, H. Miyoshi, and T. S. Stappenbeck, Development of a primary mouse intestinal epithelial cell monolayer culture system to evaluate factors that modulate IgA transcytosis, Mucosal Immunol, vol.7, pp.818-828, 2014.

I. J. Hidalgo, T. J. Raub, and R. T. Borchardt, Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability, Gastroenterology, vol.96, pp.736-749, 1989.

S. Grüneberg, S. Güssregen, ;. R. Drug-bioavailability, H. Mannhold, G. Kubinyi et al., Estimation of Solubility, Permeability, Absorption and Bioavailability. (Series: Methods and Principles in Medicinal Chemistry, vol.18, pp.146-147, 2004.

J. M. Gamboa and K. W. Leong, In vitro and in vivo models for the study of oral delivery of nanoparticles, Adv Drug Deliv Rev, vol.65, pp.800-810, 2013.

N. Li, Z. Sui, Y. Liu, D. Wang, G. Ge et al., A fast screening model for drug permeability assessment based on native small intestinal extracellular matrix, RSC Adv, vol.8, pp.34514-34524, 2018.

R. Nunes, C. Silva, and L. Chaves, 2 -Tissue-based in vitro and ex vivo models for intestinal permeability studies, vol.4, pp.203-236, 2016.

N. Sachan, A. Bhattacharya, S. Pushkar, and A. Mishra, Biopharmaceutical classification system: A strategic tool for oral drug delivery technology, Asian Journal of Pharmaceutics, vol.3, p.76, 2009.

E. Kubaszewski, A. Peters, S. Mcclain, D. Bohr, and T. Malinski, Light-activated release of nitric oxide from vascular smooth muscle of normotensive and hypertensive rats, Biochem Biophys Res Commun, vol.200, pp.213-218, 1994.

R. F. Furchgott, S. J. Ehrreich, and E. Greenblatt, The Photoactivated Relaxation of Smooth Muscle of Rabbit Aorta, J Gen Physiol, vol.44, pp.499-419, 1961.

F. W. Flitney and I. L. Megson, Nitric Oxide and the Mechanism of Rat Vascular Smooth Muscle Photorelaxation, The Journal of Physiology, vol.550, pp.819-828, 2003.

J. Stoclet, E. Troncy, B. Muller, C. Brua, and A. L. Kleschyov, Molecular mechanisms underlying the role of nitric oxide in the cardiovascular system, Expert Opinion on Investigational Drugs, vol.7, pp.1769-1779, 1998.

M. Kakuyama, P. Vallance, and A. Ahluwalia, Endothelium-dependent sensory NANC vasodilatation: involvement of ATP, CGRP and a possible NO store, British Journal of Pharmacology, vol.123, pp.310-316, 1998.

M. R. Terluk, J. E. Da-silva-santos, and J. Assreuy, Involvement of soluble guanylate cyclase and calcium-activated potassium channels in the long-lasting hyporesponsiveness to phenylephrine induced by nitric oxide in rat aorta, Naunyn-Schmied Arch Pharmacol, vol.361, pp.477-483, 2000.

P. R. Myers, R. L. Minor, R. Guerra, J. N. Bates, and D. G. Harrison, Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide, Nature, vol.345, pp.161-163, 1990.

B. Mayer, S. Pfeiffer, A. Schrammel, D. Koesling, K. Schmidt et al., A new pathway of nitric oxide/cyclic GMP signaling involving S-nitrosoglutathione, J Biol Chem, vol.273, pp.3264-3270, 1998.

A. Mülsch, A. Vanin, P. Mordvintcev, S. Hauschildt, and R. Busse, NO accounts completely for the oxygenated nitrogen species generated by enzymic L-arginine oxygenation, Biochem J, vol.288, pp.597-603, 1992.

N. Hogg, R. J. Singh, E. Konorev, J. Joseph, and B. Kalyanaraman, S-Nitrosoglutathione as a substrate for gamma-glutamyl transpeptidase, Biochem J, vol.323, issue.2, pp.477-481, 1997.

J. S. Stamler, O. Jaraki, J. Osborne, D. I. Simon, J. Keaney et al., Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin, Proc Natl Acad Sci, vol.89, pp.7674-7677, 1992.

J. F. Ewing, D. V. Young, D. R. Janero, D. S. Garvey, and T. A. Grinnell, Nitrosylated bovine serum albumin derivatives as pharmacologically active nitric oxide congeners, J Pharmacol Exp Ther, vol.283, pp.947-954, 1997.

L. Jia, C. Bonaventura, J. Bonaventura, and J. S. Stamler, S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control, Nature, vol.380, pp.221-226, 1996.

A. J. Gow and J. S. Stamler, Reactions between nitric oxide and haemoglobin under physiological conditions, Nature, vol.391, pp.169-173, 1998.

H. Lewandowska, M. Kalinowska, K. Brzóska, K. Wójciuk, G. Wójciuk et al., Nitrosyl iron complexes-synthesis, structure and biology, Dalton Trans, vol.40, pp.8273-8289, 2011.

A. J. Vithayathil, J. L. Ternberg, and B. Commoner, Changes in Electron Spin Resonance Signals of Rat Liver During Chemical Carcinogenesis, Nature, vol.207, p.1246, 1965.

M. E. Galagan, E. V. Oranovskaia, P. I. Mordvintsev, O. S. Medvedev, and A. F. Vanin,

, Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR, vol.11, pp.75-80, 1988.

A. F. Vanin, L. N. Kubrina, S. V. Kiladze, and D. S. Burbaev, Factors influencing formation of dinitrosyl complexes of non-heme iron in vitro preparations of mouse liver and yeasts, Biofizika, vol.22, pp.646-650, 1977.

A. F. Vanin, Endothelium-derived relaxing factor is a nitrosyl iron complex with thiol ligands, FEBS Letters, vol.289, pp.1-3, 1991.

A. F. Vanin, I. V. Malenkova, and V. A. Serezhenkov, Iron Catalyzes both Decomposition and Synthesis ofS-Nitrosothiols: Optical and Electron Paramagnetic Resonance Studies, Nitric Oxide, vol.1, pp.191-203, 1997.

E. B. Manukhina, B. V. Smirin, I. Y. Malyshev, J. C. Stoclet, B. Muller et al., Nitric oxide storage in the cardiovascular system, Biol Bull, vol.29, pp.477-486, 2002.

J. Haendeler, J. Hoffmann, V. Tischler, B. C. Berk, A. M. Zeiher et al., Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69, Nat Cell Biol, vol.4, pp.743-749, 2002.

D. Nikitovic and A. Holmgren, S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide, J Biol Chem, vol.271, pp.19180-19185, 1996.

A. Zai, M. A. Rudd, A. W. Scribner, and J. Loscalzo, Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide, J Clin Invest, vol.103, pp.393-399, 1999.

I. Sliskovic, A. Raturi, and B. Mutus, Characterization of the S-denitrosation activity of protein disulfide isomerase, J Biol Chem, vol.280, pp.8733-8741, 2005.

S. Dimmeler, J. Haendeler, M. Nehls, and A. M. Zeiher, Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases, J Exp Med, vol.185, pp.601-607, 1997.

H. A. Hadi, C. S. Carr, A. Suwaidi, and J. , Endothelial Dysfunction: Cardiovascular Risk Factors, Therapy, and Outcome. Vasc Health Risk Manag, vol.1, pp.183-198, 2005.

D. H. Endemann and E. L. Schiffrin, Endothelial dysfunction, J Am Soc Nephrol, vol.15, pp.1983-1992, 2004.

V. Fonseca, C. Desouza, S. Asnani, and I. Jialal, Nontraditional Risk Factors for Cardiovascular Disease in Diabetes, Endocr Rev, vol.25, pp.153-175, 2004.

P. Rajendran, T. Rengarajan, J. Thangavel, Y. Nishigaki, D. Sakthisekaran et al., The Vascular Endothelium and Human Diseases, Int J Biol Sci, vol.9, pp.1057-1069, 2013.

D. S. Celermajer, K. E. Sorensen, V. M. Gooch, D. J. Spiegelhalter, O. I. Miller et al., Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis, Lancet, vol.340, pp.1111-1115, 1992.

H. O. Steinberg, H. Chaker, R. Leaming, A. Johnson, G. Brechtel et al.,

, Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance, J Clin Invest, vol.97, pp.2601-2610, 1996.

T. Anna, M. Jansson-jan-hå-kan, B. Kurt, K. Nilsson-torbjörn, H. Lars et al., High Plasminogen Activator Inhibitor and Tissue Plasminogen Activator Levels in Plasma Precede a First Acute Myocardial Infarction in Both Men and Women, vol.98, pp.2241-2247, 1998.

M. Cushman, R. N. Lemaitre, L. H. Kuller, B. M. Psaty, E. M. Macy et al., Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study, Arterioscler Thromb Vasc Biol, vol.19, pp.493-498, 1999.

S. Fichtlscherer, G. Rosenberger, D. H. Walter, S. Breuer, S. Dimmeler et al., Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease, Circulation, vol.102, pp.1000-1006, 2000.

A. Prasad, J. Zhu, J. Halcox, M. A. Waclawiw, S. E. Epstein et al., Predisposition to atherosclerosis by infections: role of endothelial dysfunction, Circulation, vol.106, pp.184-190, 2002.

I. Singh and V. Rana, Iron oxide induced enhancement of mucoadhesive potential of Eudragit RLPO: formulation, evaluation and optimization of mucoadhesive drug delivery system, Expert Opinion on Drug Delivery, vol.10, pp.1179-1191, 2013.

S. L. Pandey, P. Jirwankar, S. P. Mehta, S. P. Pandit, P. K. Tripathi et al., Formulation and evaluation of bilayered gastroretentable mucoadhesive patch for stomach-specific drug delivery, Current drug delivery, vol.10, pp.374-383, 2013.

S. Ding, C. A. Serra, T. F. Vandamme, W. Yu, and A. N. , Double emulsions prepared by twostep emulsification: History, state-of-the-art and perspective, Journal of Controlled Release, vol.295, pp.31-49, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02273441

T. K. Giri, C. Choudhary, A. A. Ajazuddin, H. Badwaik, and D. K. Tripathi, Prospects of pharmaceuticals and biopharmaceuticals loaded microparticles prepared by double emulsion technique for controlled delivery, Saudi Pharmaceutical Journal, vol.21, pp.125-141, 2013.

G. Crotts and T. G. Park, Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: Release kinetics and stability issues, Journal of Microencapsulation, vol.15, pp.699-713, 1998.

M. Van-de-weert, J. Hoechstetter, W. E. Hennink, and D. J. Crommelin, The effect of a water/organic solvent interface on the structural stability of lysozyme, J Control Release, vol.68, pp.351-359, 2000.

G. Lautner, M. E. Meyerhoff, and S. P. Schwendeman, Biodegradable poly(lactic-co-glycolic acid) microspheres loaded with S-nitroso-N-acetyl-D-penicillamine for controlled nitric oxide delivery, J Control Release, vol.225, pp.133-139, 2016.

K. C. Kwan, Oral Bioavailability and First-Pass Effects, Drug Metab Dispos, vol.25, pp.1329-1336, 1997.

J. Renukuntla, A. D. Vadlapudi, A. Patel, S. Boddu, and A. K. Mitra, Approaches for enhancing oral bioavailability of peptides and proteins, Int J Pharm, vol.447, pp.75-93, 2013.

J. J. Doel, N. Benjamin, M. P. Hector, M. Rogers, and R. P. Allaker, Evaluation of bacterial nitrate reduction in the human oral cavity, Eur J Oral Sci, vol.113, pp.14-19, 2005.

J. O. Lundberg, E. Weitzberg, J. A. Cole, and N. Benjamin, Nitrate, bacteria and human health, Nat Rev Microbiol, vol.2, pp.593-602, 2004.

A. Boehme, Über Nitritvergiftung nach interner Darreichung von Bismuthum subnitricum, Archiv für experimentelle Pathologie und Pharmakologie, vol.57, pp.441-454, 2005.

S. Shiva, Z. Huang, R. Grubina, J. Sun, L. A. Ringwood et al., Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration, Circ Res, vol.100, pp.654-661, 2007.

Z. Huang, S. Shiva, D. B. Kim-shapiro, R. P. Patel, L. A. Ringwood et al., Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control, J Clin Invest, vol.115, pp.2099-2107, 2005.

K. Cosby, K. S. Partovi, J. H. Crawford, R. P. Patel, C. D. Reiter et al., Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation, Nat Med, vol.9, pp.1498-1505, 2003.

W. F. Alzawahra, M. Talukder, X. Liu, A. Samouilov, and J. L. Zweier, Heme proteins mediate the conversion of nitrite to nitric oxide in the vascular wall, Am J Physiol Heart Circ Physiol, vol.295, pp.499-508, 2008.

A. J. Webb, A. B. Milsom, K. S. Rathod, W. L. Chu, S. Qureshi et al., Mechanisms underlying erythrocyte and endothelial nitrite reduction to nitric oxide in hypoxia: role for xanthine oxidoreductase and endothelial nitric oxide synthase, Circ Res, vol.103, pp.957-964, 2008.

C. Gautier, E. Van-faassen, I. Mikula, P. Martasek, and A. Slama-schwok, Endothelial nitric oxide synthase reduces nitrite anions to NO under anoxia, Biochem Biophys Res Commun, vol.341, pp.816-821, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00094295

Z. Zhang, D. P. Naughton, D. R. Blake, N. Benjamin, C. R. Stevens et al., Human xanthine oxidase converts nitrite ions into nitric oxide (NO), Biochem Soc Trans, vol.25, p.524, 1997.

J. E. Baker, J. Su, X. Fu, A. Hsu, G. J. Gross et al., Nitrite confers protection against myocardial infarction: role of xanthine oxidoreductase, NADPH oxidase and K(ATP) channels, J Mol Cell Cardiol, vol.43, pp.437-444, 2007.

P. Lu, F. Liu, Z. Yao, C. Wang, D. Chen et al., Nitrite-derived nitric oxide by xanthine oxidoreductase protects the liver against ischemia-reperfusion injury, HBPD INT, vol.4, pp.350-355, 2005.

A. Webb, R. Bond, P. Mclean, R. Uppal, N. Benjamin et al., Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage, Proc Natl Acad Sci, vol.101, pp.13683-13688, 2004.

N. H. Golwala, C. Hodenette, S. N. Murthy, B. D. Nossaman, and P. J. Kadowitz, Vascular responses to nitrite are mediated by xanthine oxidoreductase and mitochondrial aldehyde dehydrogenase in the rat, Can J Physiol Pharmacol, vol.87, pp.1095-1101, 2009.

A. R. Maher, A. B. Milsom, P. Gunaruwan, K. Abozguia, I. Ahmed et al., Hypoxic modulation of exogenous nitrite-induced vasodilation in humans, Circulation, vol.117, pp.670-677, 2008.

C. Duncan, H. Dougall, P. Johnston, S. Green, R. Brogan et al., Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate, Nat Med, vol.1, pp.546-551, 1995.

G. M. Mcknight, L. M. Smith, R. S. Drummond, C. W. Duncan, M. Golden et al., Chemical synthesis of nitric oxide in the stomach from dietary nitrate in humans, Gut, vol.40, pp.211-214, 1997.

J. O. Lundberg, E. Weitzberg, J. M. Lundberg, and K. Alving, Intragastric nitric oxide production in humans: measurements in expelled air, Gut, vol.35, pp.1543-1546, 1994.

N. Benjamin, F. O'driscoll, H. Dougall, C. Duncan, L. Smith et al., Stomach NO synthesis, Nature, vol.368, p.502, 1994.

C. Oplä-nder, C. M. Volkmar, A. Paunel-görgülü, E. E. Van-faassen, C. Heiss et al., Whole body UVA irradiation lowers systemic blood pressure by release of nitric oxide from intracutaneous photolabile nitric oxide derivates, Circ Res, vol.105, pp.1031-1040, 2009.

J. L. Zweier, H. Li, A. Samouilov, and X. Liu, Mechanisms of nitrite reduction to nitric oxide in the heart and vessel wall, Nitric Oxide, vol.22, pp.83-90, 2010.

P. Artursson and J. Karlsson, Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells, Biochem Biophys Res Commun, vol.175, pp.880-885, 1991.

S. Yamashita, T. Furubayashi, M. Kataoka, T. Sakane, H. Sezaki et al., Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells, Eur J Pharm Sci, vol.10, pp.195-204, 2000.

G. Fetih, F. Habib, H. Katsumi, N. Okada, T. Fujita et al., Excellent Absorption Enhancing Characteristics of NO Donors for Improving the Intestinal Absorption of Poorly Absorbable Compound Compared with Conventional Absorption Enhancers, Drug Metabolism and Pharmacokinetics, vol.21, pp.222-229, 2006.

N. Numata, K. Takahashi, N. Mizuno, N. Utoguchi, Y. Watanabe et al., Improvement of intestinal absorption of macromolecules by nitric oxide donor, J Pharm Sci, vol.89, pp.1296-1304, 2000.

A. Yamamoto, H. Tatsumi, M. Maruyama, T. Uchiyama, N. Okada et al., Modulation of Intestinal Permeability by Nitric Oxide Donors: Implications in Intestinal Delivery of Poorly Absorbable Drugs, J Pharmacol Exp Ther, vol.296, pp.84-90, 2001.

A. L. Salzman, M. J. Menconi, N. Unno, R. M. Ezzell, D. M. Casey et al., Nitric oxide dilates tight junctions and depletes ATP in cultured Caco-2BBe intestinal epithelial monolayers, Am J Physiol, vol.268, pp.361-373, 1995.

L. Ferrec, E. Chesne, C. Artusson, P. Brayden, D. Fabre et al., In vitro models of the intestinal barrier. The report and recommendations of ECVAM Workshop 46. European Centre for the Validation of Alternative methods, Altern Lab Anim, vol.29, pp.649-668, 2001.

J. L. Alencar, I. Lobysheva, M. Geffard, M. Sarr, C. Schott et al., Role of S-nitrosation of cysteine residues in long-lasting inhibitory effect of nitric oxide on arterial tone, Mol Pharmacol, vol.63, pp.1148-1158, 2003.

K. Hayashi, P. Jutabha, T. Kamai, H. Endou, and N. Anzai, LAT1 is a central transporter of essential amino acids in human umbilical vein endothelial cells, J Pharmacol Sci, vol.124, pp.511-513, 2014.

J. A. Riego, K. A. Broniowska, N. J. Kettenhofen, and N. Hogg, Activation and inhibition of soluble guanylyl cyclase by S-nitrosocysteine: involvement of amino acid transport system L, Free Radic Biol Med, vol.47, pp.269-274, 2009.

E. Belcastro, W. Wu, I. Fries-raeth, A. Corti, A. Pompella et al., Oxidative stress enhances and modulates protein S-nitrosation in smooth muscle cells exposed to Snitrosoglutathione, Nitric Oxide, vol.69, pp.10-21, 2017.

F. Dahboul, P. Leroy, M. Gate, K. Boudier, A. Gaucher et al., Endothelial ?-glutamyltransferase contributes to the vasorelaxant effect of Snitrosoglutathione in rat aorta, PLoS ONE, vol.7, p.43190, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01491876

F. Dahboul, C. Perrin-sarrado, A. Boudier, I. Lartaud, R. Schneider et al., a new nitric oxide donor, induces a better vasorelaxation than other S-nitrosothiols, Eur J Pharmacol, vol.730, pp.171-179, 2014.
URL : https://hal.archives-ouvertes.fr/hal-00967357

C. M. Pastor and T. R. Billiar, Nitric oxide causes hyporeactivity to phenylephrine in isolated perfused livers from endotoxin-treated rats, Am J Physiol, vol.268, pp.177-182, 1995.

J. L. Alencar, K. Chalupsky, M. Sarr, V. Schini-kerth, A. F. Vanin et al., Inhibition of arterial contraction by dinitrosyl-iron complexes: critical role of the thiol ligand in determining rate of nitric oxide (NO) release and formation of releasable NO stores by S-nitrosation, Biochem Pharmacol, vol.66, pp.2365-2374, 2003.

J. L. Alencar, I. Lobysheva, K. Chalupsky, M. Geffard, F. Nepveu et al., Snitrosating nitric oxide donors induce long-lasting inhibition of contraction in isolated arteries, J Pharmacol Exp Ther, vol.307, pp.152-159, 2003.

E. Nozik-grayck, E. J. Whalen, J. S. Stamler, T. J. Mcmahon, P. Chitano et al., Snitrosoglutathione inhibits alpha1-adrenergic receptor-mediated vasoconstriction and ligand binding in pulmonary artery, Am J Physiol Lung Cell Mol Physiol, vol.290, pp.136-143, 2006.

S. S. Tate and A. Meister, Serine-borate complex as a transition-state inhibitor of gammaglutamyl transpeptidase, Proc Natl Acad Sci, vol.75, pp.4806-4809, 1978.

D. Mclaggan, H. Rufino, M. Jaspars, and I. R. Booth, Glutathione-Dependent Conversion of N-Ethylmaleimide to the Maleamic Acid by Escherichia coli: an Intracellular Detoxification Process, Appl Environ Microbiol, vol.66, pp.1393-1399, 2000.

I. J. Castellanos, K. G. Carrasquillo, J. López, M. Alvarez, and K. Griebenow, Encapsulation of bovine serum albumin in poly(lactide-co-glycolide) microspheres by the solid-in-oil-inwater technique, Journal of Pharmacy and Pharmacology, vol.53, pp.167-178, 2001.

F. Emami, A. Vatanara, E. J. Park, and D. H. Na, Drying Technologies for the Stability and Bioavailability of Biopharmaceuticals, Pharmaceutics, vol.10, 2018.

S. L. Levit, R. M. Stwodah, C. Tang, and . Rapid, Room Temperature Nanoparticle Drying and Low-Energy Reconstitution via Electrospinning, J Pharm Sci, vol.107, p.205, 2018.

F. Iskandar, L. Gradon, and K. Okuyama, Control of the morphology of nanostructured particles prepared by the spray drying of a nanoparticle sol, Journal of Colloid and Interface Science, vol.265, pp.296-303, 2003.

D. O. Schairer, J. S. Chouake, J. D. Nosanchuk, and A. J. Friedman, The potential of nitric oxide releasing therapies as antimicrobial agents, Virulence, vol.3, pp.271-279, 2012.

J. Marcinkiewicz, Nitric oxide and antimicrobial activity of reactive oxygen intermediates, Immunopharmacology, vol.37, pp.35-41, 1997.

J. R. Laver, T. M. Stevanin, S. L. Messenger, A. D. Lunn, M. E. Lee et al., Bacterial nitric oxide detoxification prevents host cell S-nitrosothiol formation: a novel mechanism of bacterial pathogenesis, FASEB J, vol.24, pp.286-295, 2010.

R. A. Souza-lima, S. Cariello, A. J. , M. Bispo, S. et al., Bactericidal Effect Of Nitric Oxide Donors Against Clinical Isolates From Keratitis, Invest Ophthalmol Vis Sci, vol.52, pp.5839-5839, 2011.

J. P. Richie, L. Skowronski, P. Abraham, and Y. Leutzinger, Blood glutathione concentrations in a large-scale human study, Clin Chem, vol.42, pp.64-70, 1996.

L. Z. Benet, C. M. Hosey, O. Ursu, and T. I. Oprea, BDDCS, the Rule of 5 and Drugability, Adv Drug Deliv Rev, vol.101, pp.89-98, 2016.

S. Bhal, LogP-Making Sense of the Value, p.4

G. De-souza, S. Ferreira-e-da, V. Baldim, and M. G. De-oliveira, Metabolic fate of Snitrosoglutathione after oral administration: Where does NO go, Nitric Oxide, vol.27, p.35, 2012.

H. Yu, J. Bonetti, C. Gaucher, I. Fries, L. Vernex-loset et al., Higher-energy collision-induced dissociation for the quantification by liquid chromatography/tandem ion trap mass spectrometry of nitric oxide metabolites coming from S-nitrosoglutathione in an in vitro model of the intestinal barrier, Rapid Communications in Mass Spectrometry, vol.33, pp.1-11, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02044975

Y. Haiyan, R. S. , A. S. Patrick, C. Pierre, and L. , Comparison between two derivatization methods of nitrite ion labeled with 15N applied to liquid chromatographytandem mass spectrometry, Anal Methods, vol.10, pp.3830-3836, 2018.

H. Björne, J. Petersson, M. Phillipson, E. Weitzberg, L. Holm et al., Nitrite in saliva increases gastric mucosal blood flow and mucus thickness, J Clin Invest, vol.113, pp.106-114, 2004.

X. Zhou and P. He, Improved measurements of intracellular nitric oxide in intact microvessels using 4,5-diaminofluorescein diacetate, Am J Physiol Heart Circ Physiol, vol.301, pp.108-114, 2011.

R. Liu, Q. Fu, S. Lonergan, E. Huff-lonergan, L. Xing et al., Identification of Snitrosylated proteins in postmortem pork muscle using modified biotin switch method coupled with isobaric tags, Meat Sci, vol.145, pp.431-439, 2018.

P. Nacharaju, C. Tuckman-vernon, K. E. Maier, J. Chouake, A. Friedman et al., A nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine: sustained vascular response, Nitric Oxide, vol.27, pp.150-160, 2012.

. Souza-gfp-de, M. G. Oliveira, and . De, Intratablet S-nitrosation: A New Approach for the Oral Administration of S-nitrosothiols as Nitric Oxide Donors, JPharmSci, vol.105, pp.359-361, 2016.

P. Fonte, P. R. Lino, V. Seabra, A. J. Almeida, S. Reis et al., Annealing as a tool for the optimization of lyophilization and ensuring of the stability of protein-loaded PLGA nanoparticles, International Journal of Pharmaceutics, vol.503, pp.163-173, 2016.

P. Fonte, S. Reis, and B. Sarmento, Facts and evidences on the lyophilization of polymeric nanoparticles for drug delivery, Journal of Controlled Release, vol.225, pp.75-86, 2016.

L. Niu and J. Panyam, Freeze concentration-induced PLGA and polystyrene nanoparticle aggregation: Imaging and rational design of lyoprotection, Journal of Controlled Release, vol.248, pp.125-132, 2017.

S. Thakral, N. K. Thakral, and D. K. Majumdar, Eudragit®: a technology evaluation, Expert Opinion on Drug Delivery, vol.10, pp.131-149, 2013.

P. Chn, R. Priya, S. Swain, K. Jena, G. Panigrahi et al., Pharmaceutical significance of Eudragit: A review, Future Journal of Pharmaceutical Sciences, vol.3, pp.33-45, 2017.

, 2225 (s), 1699 (w), 1606 (s), 1510 (s), 1646 (w), 1407 (w), 1299 (w), 1254 (s), 1176 (s, p.1036

M. Parent, F. Dahboul, R. Schneider, I. Clarot, and P. Maincent, Curr. Pharm. Anal, issue.9, p.31, 2013.

W. Wu, C. Gaucher, R. Diab, I. Fries, Y. Xiao et al., Eur. J. Pharm. Biopharm, vol.89, p.1, 2015.